MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
基本信息
- 批准号:9765041
- 负责人:
- 金额:$ 105.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-26 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvisory CommitteesAfrican AmericanAgeAwardAwarenessBasic ScienceBioinformaticsBiometryCancer BurdenCancer CenterClinical ResearchClinical TrialsCollaborationsCommunitiesCommunity HealthCore FacilityDevelopmentDiagnosisDisciplineEducationEducation and OutreachEffectivenessEnvironmentFacultyFosteringGeneral HospitalsGeographyGoalsGrowthHealth EducatorsIncidenceInstitutionJointsMalignant NeoplasmsMeasurableMedical StudentsMinorityMinority-Serving InstitutionMissionMonitorNCI Center for Cancer ResearchNCI-Designated Cancer CenterOutcomePathologyPathway interactionsPeer ReviewPopulationPublicationsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesSeriesTennesseeTranslational ResearchTriad Acrylic ResinUnderrepresented MinorityUniversitiesWorkanticancer researchbasecancer educationcancer health disparitycancer therapycancer typecareercareer developmentcollaborative approachcommunity organizationsdesigndisparity reductioneducation researchgraduate studenthealth disparityhealthcare communityhigh schoolimprovedimproved outcomemedical schoolsmortalitymultidisciplinaryoncology trialoutreachoutreach programprogramsresearch and developmentundergraduate student
项目摘要
SUMMARY
Particular emphasis is devoted in the US to identify the determinants of, and eventually remedies, for the
disproportionate share of the cancer burden borne by underrepresented minorities. Incidence rates for many
forms of cancer are higher among blacks than whites. The disparity is compounded by lower rates of relative
survival for almost all cancers, so that age-adjusted mortality rates are substantially higher among African
Americans than whites for about two-thirds of all types of cancers. Our Cancer Partnership provides an
exceptional environment to focus the efforts of diverse investigators working across many disciplines to
address health disparities in NCI designated cancer centers and to develop research infrastructure, capacity
and effectiveness of minority-serving institutions. Collectively, these efforts offer the best opportunity to
overcome cancer disparities and optimize research resources and infrastructure. Our Partnership has matured
and developed strong, successful collaborative interactions based on excellence, true reciprocity and mutual
benefit to achieve this goal. Moreover, this Partnership is geographically placed in a region with the highest
cancer incidence in the US, pointing to the enormous potential for improved outcomes through the proposed
work. We are dedicated to enhancing the strengths and eliminating the weaknesses of our three institutions as
we move toward our shared goal of eliminating cancer disparities. The overall objectives of this competing
renewal application are to: (1) increase and stabilize the competitive cancer research capability of Meharry
Medical College (MMC) and Tennessee State University (TSU); (2) create stable, long-term collaborative
relationships between MMC, TSU and the Vanderbilt Ingram Cancer Center (VICC) in cancer research,
research education, career development and cancer outreach; (3) expand access to clinical trials for minority
populations served by Nashville General Hospital (NGH)/MMC, and (4) improve the effectiveness of VICC
research, career development, education and outreach activities specifically designed to benefit minority
populations served by VICC. All activities will be monitored by an Internal Advisory Committee and the
Program Steering Committee with representation from the NCI. A sustained and comprehensive Cancer
Partnership is of immense benefit to the three participating institutions as well as the mid-South region of the
US. The common mission statement for our Cancer Partnership is to conduct rigorous basic, translational and
clinical research directed towards the reduction of disparities in the incidence and treatment of cancer through
a multidisciplinary collaborative approach to research, education and community engagement. As a triad we
will amplify cancer research capabilities in the greater Nashville academic and healthcare community, improve
and document outcomes in the diagnosis and treatment of cancer in minority and underserved communities,
minimize or eliminate measurable disparities in the incidence of cancer among minority populations, and fortify
collaborations among the three partner organizations.
总结
特别强调的是专门在美国确定的决定因素,并最终补救措施,为
代表性不足的少数群体承担的癌症负担比例过高。许多人的发病率
黑人患癌症的比例高于白人。相对失业率较低,加剧了这种差距
几乎所有癌症的存活率,因此非洲人的年龄调整死亡率要高得多。
美国人比白人约三分之二的所有类型的癌症。我们的癌症伙伴关系提供了一个
特殊的环境,集中不同的调查人员的努力,在许多学科,
解决NCI指定癌症中心的健康差距,并发展研究基础设施,
为少数群体服务的机构的效率。总的来说,这些努力提供了最好的机会,
克服癌症差异,优化研究资源和基础设施。我们的合作关系已经成熟
并基于卓越、真正的互惠和互利,
有利于实现这一目标。此外,这一伙伴关系在地理上处于一个最高的区域,
美国的癌症发病率,指出通过拟议的措施改善结果的巨大潜力
工作我们致力于加强我们三个机构的优势和消除弱点,
我们朝着消除癌症差异的共同目标前进。这场竞争的总体目标是
更新申请的目的是:(1)提高和稳定Meharry的竞争性癌症研究能力
医学院(MMC)和田纳西州立大学(大津);(2)建立稳定,长期的合作关系
MMC、大津和范德比尔特英格拉姆癌症中心(VICC)在癌症研究中的关系,
研究教育、职业发展和癌症外展;(3)扩大少数群体获得临床试验的机会
由纳什维尔总医院(NGH)/MMC服务的人群,以及(4)提高VICC的有效性
专门为少数群体开展的研究、职业发展、教育和外联活动
VICC服务的人群。所有活动将由内部咨询委员会和
由NCI代表的计划指导委员会。持续和全面的癌症
伙伴关系对这三个参与机构以及非洲中南部地区都有巨大的好处。
我们我们的癌症伙伴关系的共同使命声明是进行严格的基础,转化和
临床研究旨在减少癌症发病率和治疗方面的差异,
一个多学科的合作方法,研究,教育和社区参与。作为一个三合会,我们
将增强纳什维尔学术界和医疗保健界的癌症研究能力,
并记录少数民族和服务不足社区癌症诊断和治疗的成果,
最大限度地减少或消除少数群体癌症发病率的可衡量差异,并加强
三个伙伴组织之间的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samuel Evans Adunyah其他文献
Samuel Evans Adunyah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samuel Evans Adunyah', 18)}}的其他基金
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
MMC、VICC
- 批准号:
8534727 - 财政年份:2011
- 资助金额:
$ 105.16万 - 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
- 批准号:
10012757 - 财政年份:2011
- 资助金额:
$ 105.16万 - 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
- 批准号:
9356457 - 财政年份:2011
- 资助金额:
$ 105.16万 - 项目类别:
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
MMC、VICC
- 批准号:
9211638 - 财政年份:2011
- 资助金额:
$ 105.16万 - 项目类别:
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
1/3) MMC、VICC 和 TSU:消除癌症差异的合作伙伴
- 批准号:
10493417 - 财政年份:2011
- 资助金额:
$ 105.16万 - 项目类别:
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
1/3) MMC、VICC 和 TSU:消除癌症差异的合作伙伴
- 批准号:
10705089 - 财政年份:2011
- 资助金额:
$ 105.16万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 105.16万 - 项目类别:
Standard Grant